Rocket


News + Filings
Transactions





Goldman Steven Harold

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/31/2012Tribute Pharmaceuticals Canada Inc.TBUFFPurchaseCommon Shares15k$0.46$6.9kLambent Consulting Corp08/31/2012
08/31/2012Tribute Pharmaceuticals Canada Inc.TBUFFPurchaseCommon Shares5k$0.49$2.4kLambent Consulting Corp08/31/2012
08/31/2012Tribute Pharmaceuticals Canada Inc.TBUFFPurchaseCommon Shares15k$0.49$7.4kLambent Consulting Corp08/31/2012
12/20/2011Tribute Pharmaceuticals Canada Inc.TBUFFGrantCommon Shares21.1k$0.68$14.3kSpousal Ownership12/20/2011
12/20/2011Tribute Pharmaceuticals Canada Inc.TBUFFGrantCommon Shares5.4k$0.66$3.6kSpousal ownership12/20/2011
12/20/2011Tribute Pharmaceuticals Canada Inc.TBUFFGrantCommon Shares11k$0.65$7.2kSpousal ownership12/20/2011
12/20/2011Tribute Pharmaceuticals Canada Inc.TBUFFGrantCommon Shares1.5k$0.63$945Spousal ownership12/20/2011
12/19/2011Tribute Pharmaceuticals Canada Inc.TBUFFGrantCommon Shares5k$0.65$3.2kLambent Consulting Corp12/15/2011
12/19/2011Tribute Pharmaceuticals Canada Inc.TBUFFGrantCommon shares5k$0.63$3.2kSpousal ownership12/15/2011
12/15/2011Tribute Pharmaceuticals Canada Inc.TBUFFGrantCommon Shares50k$0.66$33kLambent Consulting Corp12/15/2011
07/01/2010Tribute Pharmaceuticals Canada Inc.TBUFFGrantShare Options (right to buy)90k$0.90$81k 07/01/2010

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy